B. Metzler seel. Sohn & Co. AG acquired a new stake in shares of AMETEK, Inc. (NYSE:AME - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 33,146 shares of the technology company's stock, valued at approximately $8,019,000.
A number of other large investors also recently bought and sold shares of AME. Virtus Advisers LLC bought a new stake in AMETEK during the 2nd quarter valued at $230,000. Silvant Capital Management LLC bought a new position in shares of AMETEK in the 2nd quarter worth $5,286,000. LaSalle St. Investment Advisors LLC bought a new position in shares of AMETEK in the 2nd quarter worth $288,000. Mystic Asset Management Inc. purchased a new stake in shares of AMETEK during the 2nd quarter worth $1,282,000. Finally, Portfolio Design Labs LLC bought a new stake in AMETEK during the second quarter valued at about $2,641,000. Institutional investors own 87.43% of the company's stock.
Insiders Place Their Bets
In other news, insider David F. Hermance sold 6,608 shares of the business's stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $254.00, for a total value of $1,678,432.00. Following the completion of the sale, the insider directly owned 42,509 shares in the company, valued at $10,797,286. The trade was a 13.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.54% of the company's stock.
AMETEK Price Performance
Shares of NYSE:AME opened at $239.54 on Friday. AMETEK, Inc. has a twelve month low of $179.24 and a twelve month high of $261.16. The company's 50 day moving average is $240.65 and its 200 day moving average is $231.93. The company has a current ratio of 1.21, a quick ratio of 0.76 and a debt-to-equity ratio of 0.09. The company has a market cap of $54.90 billion, a PE ratio of 35.02, a price-to-earnings-growth ratio of 3.11 and a beta of 0.98.
AMETEK (NYSE:AME - Get Free Report) last issued its earnings results on Tuesday, August 4th. The technology company reported $2.09 EPS for the quarter, topping analysts' consensus estimates of $1.99 by $0.10. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $1.95 billion. AMETEK had a return on equity of 16.93% and a net margin of 20.04%.The company's revenue was up 15.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.78 earnings per share. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS. On average, sell-side analysts forecast that AMETEK, Inc. will post 8.32 EPS for the current year.
AMETEK Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, September 15th. AMETEK's payout ratio is currently 19.88%.
Key Headlines Impacting AMETEK
Here are the key news stories impacting AMETEK this week:
- Positive Sentiment: Broad EPS upgrades: Zacks raised its AMETEK earnings forecasts across multiple periods, including Q3 2026 EPS to $2.08 from $2.00 and full-year 2026 EPS to $8.27 from $8.07. It also increased FY2027 EPS to $8.74 from $8.47 and FY2028 EPS to $9.33 from $9.10. AMETEK earnings estimate revisions
- Positive Sentiment: Improved longer-term outlook: Zacks also lifted estimates for Q1 and Q2 2027, Q3 and Q4 2027, and Q1 and Q2 2028. The revisions imply continued earnings growth and put Zacks’ FY2028 forecast above the current-year consensus estimate of $8.33 per share. AMETEK analyst estimates
- Neutral Sentiment: Limited immediate catalyst: The estimate changes are favorable but relate mainly to future quarters and do not represent a new contract, acquisition, or change to company guidance. Zacks’ FY2026 forecast of $8.27 remains slightly below the broader consensus estimate of $8.33.
- Negative Sentiment: Valuation may be weighing on the shares: AMETEK trades at roughly 35 times earnings and near its 52-week high. That elevated valuation could encourage profit-taking or require stronger near-term results to drive additional upside, potentially explaining the stock’s weakness despite the positive estimate revisions.
Analysts Set New Price Targets
Several research analysts recently commented on AME shares. Wall Street Zen lowered shares of AMETEK from a "buy" rating to a "hold" rating in a research note on Sunday, May 10th. TD Cowen reaffirmed a "buy" rating on shares of AMETEK in a report on Thursday, August 6th. Morgan Stanley increased their price objective on AMETEK from $235.00 to $245.00 and gave the company an "equal weight" rating in a report on Friday, July 10th. Robert W. Baird set a $275.00 price objective on AMETEK in a research report on Wednesday, August 5th. Finally, Royal Bank Of Canada upped their target price on AMETEK from $260.00 to $291.00 and gave the company an "outperform" rating in a research report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $266.80.
Check Out Our Latest Research Report on AMETEK
AMETEK Company Profile
(
Free Report)
AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.
The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.